Navigation Links
ARx(TM) Opens New Pharmaceutical Manufacturing Facility
Date:9/19/2007

Company Expanding to Meet the Global Demands for Innovative Drug Delivery

Systems

GLEN ROCK, Pa., Sept. 19 /PRNewswire/ -- ARx(TM), LLC, a subsidiary of Adhesives Research, is pleased to announce the official opening of its new state-of-the-art pharmaceutical manufacturing facility just eighteen months after breaking ground.

The new 25,000 square-foot facility is designed to manufacture dissolvable film, transdermal, and buccal drug delivery systems for over-the-counter (OTC), prescription, and biopharmaceutical products. The globally-compliant facility triples ARx's manufacturing capacity and laboratory space to support its rapidly growing portfolio of projects and clients.

ARx currently supports multiple commercial thin film products sold in the United States, Canada and Latin America, including Novartis Consumer Health's Triaminic(R) Thin Strips(TM) pediatric and infant cough and cold products, Theraflu(R) Thin Strips(TM) cold and flu products, and Gas-X(R) Thin Strips(TM) anti-gas relief products. The current facility and evolving pipeline further supports ARx's market leadership by quadrupling potential strip output to over 1.4 billion strips per year.

"We have used our knowledge and twenty-plus years of experience in the pharmaceutical industry to build a modern, globally-compliant facility that allows us to streamline the manufacturing process and create an efficient and flexible process for our clients," said Beth Vondrak, ARx Vice President and General Manager.

Dissolvable thin film technology gives consumers a choice of delivery options for taking OTC and prescription medicines. The key benefits of the technology include quick and precise dosing, convenience and portability. These films have proven to be very popular for the pediatric population, who usually ingest the entire thin film dose (versus liquids that can be expelled from the mouth), as well as with geriatric patients and other individuals who have difficulty swallowing pills and those who prefer on-the-go relief.

ARx, a subsidiary of Adhesives Research, was created in 2005 to address the growing global need for innovative delivery of active drug-containing systems and is a custom developer and supplier of high-quality drug and biopharmaceutical delivery materials and technologies for the pharmaceutical industry. Adhesives Research has over 20 years of experience in providing unique components for transdermal, oral and topical drug delivery. The new facility brings the total square footage at the company's corporate headquarters to more than 240,000 square feet.

For more information on ARx and Adhesives Research, please call 717-235-7979 (1-800-445-6240) or visit http://www.adhesivesresearch.com.


'/>"/>
SOURCE ARx, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
Breaking Medicine Technology: